Priority Date: 08.12.11 (US 201161568590P)

OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA

  • Application ID: EP12805882
  • Status: GRANT OF PATENT INTENDED

Attorney

Company dna schiweck weinzierl koch gbr
no operation time available
Headquarter in München
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 171 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 08.12.2011 - Priority Date (US 201161568590P)
  • 13.06.2013 - Publication A2 (WO2013086441)
  • 15.10.2014 - Publication A2 (EP2788487)

IPC Classification